In this double-feature episode of the OIS Eye on Innovation Podcast, Carey Powers highlights the invaluable resources and expertise within the OIS community, showcasing the power of cross-collaboration and strategic foresight in biotech.

Part 1:
Dr. Francis Lasowski (C20/20 Innovation Hub) and Dr. Wendy Naimark (Ripple Therapeutics) discuss their long-standing partnership, which has propelled Ripple's success through groundbreaking innovations, including dry AMD research and key advancements in IP management. Learn how the Innovation Hub provides early-stage companies with critical resources to navigate the challenges of development and commercialization.

Part 2:
Tracy Valorie, a biotech and pharma veteran, explains why early commercial strategy is the key to success. From understanding market access and reimbursement to planning for manufacturing readiness, Tracy shares actionable tips for startups to avoid costly mistakes and maintain a commercial mindset throughout product development.

In this episode, you’ll learn:

• How partnerships, like C20/20 and Ripple Therapeutics, foster early-stage breakthroughs.
• The role of innovation hubs in overcoming funding and IP challenges.
• Why a commercial strategy must start at the angel investing stage.
• How to integrate market research and manufacturing readiness into development plans.
• The power of collaboration and strategic foresight to accelerate biotech success.

Discover how cross-industry partnerships and early commercial planning can bridge the "valley of death" in biotech. Tune in to this episode and leverage the collective wisdom of the OIS community!